Over the past 10 years, the continual discovery of novel forms of encephalitis associated
with antibodies to cell‐surface or synaptic proteins has changed the paradigms for …

The field of autoimmune encephalitides associated with antibodies targeting cell-surface
antigens is rapidly expanding and new antibodies are discovered frequently. Typical clinical …

Seronegative autoimmune encephalitis is autoimmune encephalitis without any identifiable
pathogenic antibody. Although it is a major subtype of autoimmune encephalitis, many …

A considerable portion of autoimmune encephalitis (AE) does not respond to conventional
immunotherapies and subsequently has poor outcomes. We aimed to determine the efficacy …

We have reviewed the literature of immune therapy in autoimmune encephalitis associated
with antibodies to cell surface antigens including N-methyl-D-aspartate receptor (NMDAR) …

Objective: To determine efficacy and safety of rituximab treatment as a second-line
immunotherapy treatment for autoimmune limbic encephalitis (ALE) and to determine factors …

Objective: To compare the rate of abnormal brain metabolism by FDG-PET/CT to other
paraclinical findings and to describe brain metabolism patterns in autoimmune encephalitis …

In anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis, we analysed the efficacy of a
combined immunotherapy protocol consisting of teratoma removal, steroid, intravenous …

Aim We aim to review the literature to collate and describe features of encephalitides arising
from autoantibodies against leucine‐rich glioma‐inactivated 1 (LGI1), gamma aminobutyric …

Autoimmune encephalitis is a group of encephalitis syndromes that cause altered mentality,
memory decline, or seizures in association with the presence of serum and cerebrospinal …